213 related articles for article (PubMed ID: 35691727)
1. Equalization of Brain State Occupancy Accompanies Cognitive Impairment in Cerebral Small Vessel Disease.
Schlemm E; Frey BM; Mayer C; Petersen M; Fiehler J; Hanning U; Kühn S; Twerenbold R; Gallinat J; Gerloff C; Thomalla G; Cheng B
Biol Psychiatry; 2022 Oct; 92(7):592-602. PubMed ID: 35691727
[TBL] [Abstract][Full Text] [Related]
2. Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment.
Papma JM; de Groot M; de Koning I; Mattace-Raso FU; van der Lugt A; Vernooij MW; Niessen WJ; van Swieten JC; Koudstaal PJ; Prins ND; Smits M
Hum Brain Mapp; 2014 Jun; 35(6):2836-51. PubMed ID: 24115179
[TBL] [Abstract][Full Text] [Related]
3. Distinctive and Pervasive Alterations of Functional Brain Networks in Cerebral Small Vessel Disease with and without Cognitive Impairment.
Liu R; Wu W; Ye Q; Gu Y; Zou J; Chen X; Jiang Y; Bai F; Xu Y; Wang C
Dement Geriatr Cogn Disord; 2019; 47(1-2):55-67. PubMed ID: 30861519
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease.
Zhang W; Zhou X; Yin J; Zhao W; Huang C; Zhang C; Wan K; Li M; Zhu X; Sun Z
Brain Res; 2023 May; 1807():148318. PubMed ID: 36898474
[TBL] [Abstract][Full Text] [Related]
5. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
6. Disrupted functional and structural connectivity within default mode network contribute to WMH-related cognitive impairment.
Chen X; Huang L; Ye Q; Yang D; Qin R; Luo C; Li M; Zhang B; Xu Y
Neuroimage Clin; 2019; 24():102088. PubMed ID: 31795048
[TBL] [Abstract][Full Text] [Related]
7. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
[TBL] [Abstract][Full Text] [Related]
8. Discontinuity of deep medullary veins in SWI is associated with deep white matter hyperintensity volume and cognitive impairment in cerebral small vessel disease.
Liao M; Wang M; Li H; Li J; Yi M; Lan L; Ouyang F; Shi L; Fan Y
J Affect Disord; 2024 Apr; 350():600-607. PubMed ID: 38253134
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
10. White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health study.
Frey BM; Petersen M; Schlemm E; Mayer C; Hanning U; Engelke K; Fiehler J; Borof K; Jagodzinski A; Gerloff C; Thomalla G; Cheng B
Hum Brain Mapp; 2021 Apr; 42(5):1406-1415. PubMed ID: 33289924
[TBL] [Abstract][Full Text] [Related]
11. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
[TBL] [Abstract][Full Text] [Related]
13. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
[TBL] [Abstract][Full Text] [Related]
14. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
[TBL] [Abstract][Full Text] [Related]
16. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging.
Zhang CE; Wong SM; Uiterwijk R; Backes WH; Jansen JFA; Jeukens CRLPN; van Oostenbrugge RJ; Staals J
Brain Imaging Behav; 2019 Apr; 13(2):389-395. PubMed ID: 29572621
[TBL] [Abstract][Full Text] [Related]
18. Characteristic patterns of functional connectivity-mediated cerebral small vessel disease-related cognitive impairment and depression.
Xu J; Chen H; Hu Z; Ke Z; Qin R; Chen Y; Xu Y
Cereb Cortex; 2024 Jan; 34(1):. PubMed ID: 38061698
[TBL] [Abstract][Full Text] [Related]
19. Network Localisation of White Matter Damage in Cerebral Small Vessel Disease.
Petersen M; Frey BM; Schlemm E; Mayer C; Hanning U; Engelke K; Fiehler J; Borof K; Jagodzinski A; Gerloff C; Thomalla G; Cheng B
Sci Rep; 2020 Jun; 10(1):9210. PubMed ID: 32514044
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.
Dao E; Tam R; Hsiung GR; Ten Brinke L; Crockett R; Barha CK; Yoo Y; Al Keridy W; Doherty SH; Laule C; MacKay AL; Liu-Ambrose T
J Alzheimers Dis; 2021; 80(1):91-101. PubMed ID: 33523006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
